Skip to main content
. 2023 Aug 19;11(8):1386. doi: 10.3390/vaccines11081386
ABCDEF Advice, Burden, Conspiracy, Dangers, Efficiency, and Fear
aOR Adjusted odds ratio
CI Confidence interval
COVID-19 Coronavirus disease 2019
EFA Exploratory factor analysis
ERD Vaccine-enhanced respiratory disease
F RSV fusion glycoprotein
FDA The United States Food and Drug Administration
HBM Health Belief Model
IQR Interquartile range
JOD Jordanian dinar
KMO Kaiser-Meyer-Olkin measure
K-S Kolmogorov-Smirnov test
K-W Kruskal-Wallis test
LMICs Low- and middle-income countries
LRTI Lower respiratory tract infection
M-W Mann-Whitney U test
PCA Principal component analysis
RSV Respiratory syncytial virus
SD Standard deviation